| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |